supplementary figure 3
DESCRIPTION
HCT116. HCT116-TP53KO. NT. 5FU. Ox. NT. 5FU. Ox. 5. 2. 4. LC3. 3. IC50 5FU (µM). 1. IC50 Oxaliplatin (µM). 2. 1. GAPDH. 0. 0. HCT116. HCT116 TP53KO. HCT116. HCT116 TP53KO. 6. 5. 4. 7. HCT116. IC50 5FU (µM). 3. 6. HCT116. 0.4. 2. 5. 4. 1. 0.3. IC50 5FU (µM). - PowerPoint PPT PresentationTRANSCRIPT
Supplementary Figure 3
HCT116-TP53KO
0
1
2
3
4
5
6
siLUC siATG5 si ATG7
IC50
5F
U (
µM
)
HCT116
0
1
2
3
4
5
6
7
siLUC siATG5 si ATG7
IC50
5F
U (
µM
)
GAPDH
LC3
NT NT5FU 5FU OxOx
HCT116 HCT116-TP53KO
A B
CD
E F
012
345
HCT116 HCT116TP53KO
IC50
5F
U (
µM
)
0
1
2
HCT116 HCT116TP53KO
IC50
Oxa
lipla
tin (
µM
)
0
0.1
0.2
0.3
0.4
siLUC si ATG5 si ATG7
IC50
Oxa
lipla
tin (
µM
) HCT116
0
0.2
0.4
0.6
0.81
1.2
1.4
1.6
siLUC si ATG5 si ATG7
IC50
Oxa
lipla
tin (
µM
)
HCT116-TP53KO